Plus   Neg

CytomX Therapeutics Holding On To Strong Gain In Late-Day Trading

Shares of CytomX Therapeutics (CTMX) have pulled back off their highs of the session but continue to significant strength in late-day trading on Wednesday. After reaching its best intraday level in well over a year, CytomX is currently up by 20.5 percent.

The jump by CytomX comes after the biopharmaceutical company announced it has entered into a strategic collaboration with Amgen (AMGN) in immuno-oncology.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
In a move likely to further inflame global trade tensions, President Donald Trump has threatened to impose a 20 percent tariff on all cars imported to the U.S. from the European Union. Trump claimed he would impose the new tariffs unless the EU removes tariffs and trade barriers placed on the U.S. The Federal Reserve has determined that the largest U.S. banks are strongly capitalized and would be able to lend to banks as well as households during a severe global economic recession. This is the fourth straight year that all banks have met the Federal Reserve's standards. The first round of results of the supervisory stress tests were released by the central bank on Thursday. The "safety" driver behind the wheel of a self-driving Uber was streaming a television show on her smartphone up until about the time of a fatal crash in March, according to a report from the Tempe Police Department. Uber's self-driving Volvo SUV, which was traveling at under 44 miles per hour, had struck and killed a pedestrian in Arizona on March 18.
Follow RTT